Clenziderm Therapeutic
NDC Package 62032-113-65

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Clenziderm Therapeutic is •Wet face with warm water.•Dispense a nickel size amount of Daily Care Cream Cleanser into the palm of your hand.•Gently massage Cleanser over entire face.•Rinse skin thoroughly and pat dry.•Wait 10 minutes to allow skin to dry completely before applying Therapeutic Lotion. Marketed by Omp, Inc., this product is identified by NDC 62032-113 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
62032-113-65
Package Description
47 mL in 1 BOTTLE, PLASTIC
Product Code
62032-113
11-Digit Billing Format
62032011365
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Clenziderm Therapeutic
Dosage Form
-
Usage Information
•Wet face with warm water.•Dispense a nickel size amount of Daily Care Cream Cleanser into the palm of your hand.•Gently massage Cleanser over entire face.•Rinse skin thoroughly and pat dry.•Wait 10 minutes to allow skin to dry completely before applying Therapeutic Lotion. •Use once a day or as directed by your physician.•Clean the skin thoroughly before applying.•Pump product 1 time onto fingertip and apply evenly to entire face, avoiding the eyes, nose and mouth.•Allow Therapeutic Lotion to absorb completely before applying Therapeutic Moisturizer.•Because excessive drying of the skin may occur, start with 1 application per day.•If bothersome dryness or peeling occurs, reduce application to every other day.•If going outside, use a sunscreen: Allow Obagi CLENZIderm M.D.™ Therapeutic Lotion to dry, then follow directions in the sunscreen labeling. •Apply as needed.

Regulatory & Marketing

Labeler Name
Omp, Inc.
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
07-01-2007
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62032-113-65 identifies a specific commercial package of 47 ml in 1 bottle, plastic of Clenziderm Therapeutic, labeled by Omp, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Omp, Inc. on July 01, 2007. The current certification is valid through December 31, 2017.

How is this Omp, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62032011365. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62032-113-65
11-Digit CMS (5-4-2)
62032-0113-65

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.